MedTrace Logo

Percutaneous Biodegradable Biliary Stents for the Treatment of Benign Biliary Strictures.

NCT05556668 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-03-01

No results posted yet for this study

Summary

To assess safety and effectiveness in the long term of percutaneous insertion of Biodegradable (BD) Biliary Stents for the treatment of benign biliary strictures, in a single center experience.

Conditions

  • Biliary Stricture
  • Biliary Tract Diseases
  • Bile Duct Stricture
  • Bile Duct Injury
  • Stents
  • Obstructive Jaundice

Interventions

DEVICE

Percutaneous placement of biodegradable biliary stents

Benign biliary strictures treated with polydioxanone (PPDX) stents (Ella-DV biliary stent, ELLACS, Hradec Králové, Czech Republic). The stents are implanted using a percutaneous transhepatic cholangiography. Before stent implantation, balloon bilioplasty is be performed.

Sponsors & Collaborators

  • Universitat Autonoma de Barcelona

    collaborator OTHER

  • Corporacion Parc Tauli

    lead OTHER

Principal Investigators

  • Eva Criado-Paredes, MD · Corporació Universitaria Parc Tauli

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-20
Primary Completion
2022-11-05
Completion
2022-12-20

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05556668 on ClinicalTrials.gov